AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Clopidogrel vs Aspirin in PCI Patients
The chapter discusses a post hoc analysis of a trial comparing antiplatelet monotherapies, specifically clopidogrel and aspirin, in patients who have undergone percutaneous coronary intervention (PCI). It highlights the long-term benefits of clopidogrel in reducing adverse outcomes and ischemic events compared to aspirin. The chapter also mentions the limitations of the study and the lower risk of intracranial bleeding with clopidogrel.